Literature DB >> 11586510

A guide for diagnosis of patients with arterial and venous thrombosis.

C Quinn1, J Hill, H Hassouna.   

Abstract

Inasmuch as coagulation laboratories are involved in providing a diagnosis for underlying causes of venous and arterial thrombosis, we present a comprehensive review of the biological properties and functions of the components of the hemostatic system as they relate to the diagnosis of arterial and venous thrombosis. Moreover, as coagulation laboratories are necessary to evaluate the success of initial treatment modalities and to provide guidance for supplemental therapeutic intervention, we include information on antiplatelet and antithrombotic therapy. Included in clinical coagulation testing are assays that evaluate the potential of blood to form clots and tests for platelet numbers and platelet functions. Clot-based assays directly detect the biological activity of procoagulant factors and fibrinogen; chromogenic substrate assays evaluate proteolytic activities of clotting as well as fibrinolysis enzymes; and specific antibodies measure the concentrations of coagulation and fibrinolysis enzymes in plasma. Genetic testing is rapidly becoming incorporated into the clinical routine. The prothrombin time (PT), activated partial prothrombin time (APTT), and thrombin time (TT) are screening assays that measure the clotting times of recalcified whole blood or platelet-poor plasma. In addition to their function as screening assays, PT, APTT, and TT are the backbone of all the specialized clot-based assays for factor activities and for the indirect measurement of inhibitory antithrombin and protein C activities. Molecular markers related to hemostasis and fibrinolysis consist of proteins or peptides that indicate an ongoing physiological or abnormal process related to clot formation, thrombosis, vascular damage, or drug effect. Molecular markers are currently identified by means of specific antibodies prepared against them. The list of hemostatic molecular markers is rapidly growing. Most of the assays developed for molecular marker measurement, with the notable exception of the d-dimer assay, are typically used in clinical research.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11586510

Source DB:  PubMed          Journal:  Clin Lab Sci        ISSN: 0894-959X


  5 in total

1.  Antitcoagulant and antiplatelet activities of scolymoside.

Authors:  Eun-Kyung Yoon; Sae-Kwang Ku; Wonhwa Lee; Soyoung Kwak; Hyejin Kang; Byeongjin Jung; Jong-Sup Bae
Journal:  BMB Rep       Date:  2015-10       Impact factor: 4.778

2.  Antithrombotic and antiplatelet activities of small-molecule alkaloids from Scolopendra subspinipes mutilans.

Authors:  Wonhwa Lee; JungIn Lee; Roshan Kulkarni; Mi-Ae Kim; Jae Sam Hwang; MinKyun Na; Jong-Sup Bae
Journal:  Sci Rep       Date:  2016-02-24       Impact factor: 4.379

3.  Inhibition of platelet aggregation and thrombosis by indole alkaloids isolated from the edible insect Protaetia brevitarsis seulensis (Kolbe).

Authors:  JungIn Lee; Wonhwa Lee; Mi-Ae Kim; Jae Sam Hwang; MinKyun Na; Jong-Sup Bae
Journal:  J Cell Mol Med       Date:  2016-12-20       Impact factor: 5.310

4.  Antiplatelet and antithrombotic activities of purpurogallin in vitro and in vivo.

Authors:  Sae-Kwang Ku; Jong-Sup Bae
Journal:  BMB Rep       Date:  2014-07       Impact factor: 4.778

5.  Anticoagulant activities of piperlonguminine in vitro and in vivo.

Authors:  Wonhwa Lee; Hayoung Yoo; Sae-Kwang Ku; Jeong Ah Kim; Jong-Sup Bae
Journal:  BMB Rep       Date:  2013-10       Impact factor: 4.778

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.